FDA Inspection 1018440 — Minato Pharmaceutical Co Ltd

Minato Pharmaceutical Co Ltd — FEI 3009966334

The FDA completed an inspection of Minato Pharmaceutical Co Ltd on July 19, 2017 in Nasushiobara. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 5 citations were issued during this inspection. Product area: Food/Cosmetics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 19, 2017
Fiscal Year
2017
Product Type
Food/Cosmetics
Project Area
Food Composition, Standards, Labeling and Econ
Location
Nasushiobara (Japan)

Citations

IDCFRDescription
1570221 CFR 111.320(b)Examination, testing; scientifically valid
1573921 CFR 111.210(h)(3)(ii)(B)Components; add, verify
1574721 CFR 111.210(g)Packaging description, representative label
1576321 CFR 111.205(a)Master manufacturing record - unique formulation
1585821 CFR 111.75(a)(1)(i)Component - verify identity, dietary ingredient